Tag Archives: sickle

‘Supporters of Families with Sickle Cell’ founders are raising awareness for the disease

Loading the player… Velvet Brown-Watts, MSW-ADM, CM., and Jeremiah Watts are at the forefront of raising awareness on sickle cell in their Oklahoma community and providing resources to those impacted by the disease. The couple is not only advocates but knows what it’s like firsthand to be supportive of someone living with the disease. Their… Read More »

These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes

Kyra, left, and Kami Crawford, of San Antonio, are both living with sickle cell, a common complication of which is stroke. These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes Kyra and Kami never got a simple test that could have protected them. Their story exemplifies the failure to care for people with the… Read More »

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »

FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease

FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease Print this page SOUTH SAN FRANCISCO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) —  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta™ (voxelotor) tablets for the treatment of sickle cell disease (SCD) in adults and children… Read More »

Promising new sickle cell disease medicine wins FDA approval

This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP) After a recent decision by the FDA a better day could be… Read More »